OncorMed Inc.
🏢 View company profile →6Patents
0Active
6Granted
27Portfolio score
Filing activity: Sep 25, 1995 → Dec 11, 1997
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5642936A | Methods for identifying human hereditary disease patterns | Emerging Cross-Sectional Technologies | 136 | Expired |
| US5654155A | Consensus sequence of the human BRCA1 gene | Chemistry; Metallurgy | 14 | Expired |
| US5756294A | Susceptibility mutation for breast and ovarian cancer | Chemistry; Metallurgy | 13 | Expired |
| US6083698A | Cancer susceptibility mutations of BRCA1 | Emerging Cross-Sectional Technologies | 11 | Expired |
| US5750400A | Coding sequences of the human BRCA1 gene | Chemistry; Metallurgy | 9 | Expired |
| US6051379A | Cancer susceptibility mutations of BRCA2 | Chemistry; Metallurgy | 5 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.